New Search

Your search found 57 records, sorted by year and then date of acquisition.

1. The Prescription Opioid Addiction Treatment Study: What Have We Learned. doc type
  Weiss, Roger D. ; Rao, Vinod
 Drug and Alcohol Dependence 2017;173:S48-S54. [doi: 10.1016/j.drugalcdep.2016.12.001].
 
2. CSAT/CTN Webinar: Research and Evaluation of Treatment and Treatment Systems for Pregnant and Parenting Women with Opioid Use Disorder. doc type
  Johnson, Kimberly ; Jones, Hendree ; Goodman, Daisy ; Chapman, Steven ; Frew, Julia
 Webinar presented December 13, 2016.
 
3. Pain Volatility and Prescription Opioid Addiction Treatment Outcomes in Patients With Chronic Pain. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Experimental and Clinical Psychopharmacology 2015;23(6):428-435. [doi: 10.1037/pha0000039].
 
4. Long-term Outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Provost, Scott E. ; Fitzmaurice, Garrett M. ; McDermott, Katherine A. ; Srisarajivakul, Emily N. ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; McHugh, R. Kathryn ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2015;150:112-119. [doi: 10.1016/j.drugalcdep.2015.02.030].
 
5. Baseline Characteristics and Treatment Outcomes in Prescription Opioid Dependent Patients With and Without Co-Occurring Psychiatric Disorder. doc type
  Griffin, Margaret L. ; Dodd, Dorian R. ; Potter, Jennifer Sharpe ; Rice, Lindsay S. ; Dickinson, William ; Sparenborg, Steven ; Weiss, Roger D.
 American Journal of Drug and Alcohol Abuse 2014;40(2):157-162. [doi: 10.3109/00952990.2013.842241].
 
6. The Relationship Between Primary Prescription Opioid and Buprenorphine-Naloxone Induction Outcomes in a Prescription Opioid Dependent Sample. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen ; Weiss, Roger D. ; Mooney, Larissa ; Potter, Jennifer Sharpe ; Lee, Joshua ; Gourevitch, Marc N. ; Ling, Walter
 American Journal on Addictions 2014;23(4):343-348. [doi: 10.1111/j.1521-0391.2013.12105.x].
 
7. Lack of Association of Cannabis Use with Opioid Outcomes Among Opioid-Dependent Youth. doc type
  Hill, Kevin P. ; Bennett, Heather E. ; Griffin, Margaret L. ; Connery, Hilary Smith ; Fitzmaurice, Garrett M. ; Subramaniam, Geetha A. ; Woody, George E. ; Weiss, Roger D.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
8. Opioid Withdrawal and Craving Trajectories Following Buprenorphine Taper: A Latent Class and Growth Mixture Model of Time-to-First Opioid Lapse. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Weiss, Roger D. ; Mulpur, Swetha ; Walker, N. Robrina ; Trivedi, Madhukar H.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
9. Concordance Between Self-Report and Urine Drug Screen Data in Adolescent Opioid Dependent Clinical Trial Participants. doc type
  Wilcox, Claire E. ; Bogenschutz, Michael P. ; Nakazawa, Masato ; Woody, George E.
 Addictive Behaviors 2013;38(10):2568-2574. [doi: 10.1016/j.addbeh.2013.05.015].
 
10. Patient Characteristics Associated with Buprenorphine/Naloxone Treatment Outcome for Prescription Opioid Dependence: Results from a Multisite Study. doc type
  Dreifuss, Jessica A. ; Griffin, Margaret L. ; Frost, Katherine ; Fitzmaurice, Garrett M. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Selzer, Jeffrey A. ; Hatch-Maillette, Mary A. ; Sonne, Susan C. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2013;131(1-2):112-118. [doi: 10.1016/j.drugalcdep.2012.12.010].
 
11. Gender Differences in a Clinical Trial for Prescription Opioid Dependence. doc type
  McHugh, R. Kathryn ; DeVito, Elise E. ; Dodd, Dorian ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Greenfield, Shelly F. ; Connery, Hilary Smith ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2013;45(1):38-43. [doi: 10.1016/j.jsat.2012.12.007].
 
12. Predictors of Attrition with Buprenorphine/Naloxone Treatment in Opioid Dependent Youth. doc type
  Warden, Diane ; Subramaniam, Geetha A. ; Carmody, Thomas ; Woody, George E. ; Minhajuddin, Abu T. ; Poole, Sabrina A. ; Potter, Jennifer Sharpe ; Fishman, Marc J. ; Bogenschutz, Michael P. ; Patkar, Ashwin A. ; Trivedi, Madhukar H.
 Addictive Behaviors 2012;37(9):1046-1053. [doi: 10.1016/j.addbeh.2012.04.011].
 
13. Buprenorphine Suite of Blending Products (Blending Team Product). doc type doc type
  Blending Team Members
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2005-2012.
 
14. Advances in Clinical Research for Prescription Opioid Dependence. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D.
 Presented at the National Association of Social Workers Massachusetts Chapter Symposium, Framingham, MA, March 29-30, 2012.
 
15. Missing Data in Substance Abuse Treatment Research: Current Methods and Modern Approaches. doc type
  McPherson, Sterling ; Barbosa-Leiker, Celestina ; Burns, G. Leonard ; Howell, Donelle ; Roll, John M.
 Experimental and Clinical Psychopharmacology 2012;20(3):243-250. [doi: 10.1037/a0027146].
 
16. Compensation Effects on Clinical Trial Data Collection in Opioid-Dependent Young Adults. doc type
  Wilcox, Claire E. ; Bogenschutz, Michael P. ; Nakazawa, Masato ; Woody, George E.
 American Journal of Drug and Alcohol Abuse 2012;38(1):81-86. [doi: 10.3109/00952990.2011.600393].
 
17. Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth. doc type
  Subramaniam, Geetha A. ; Warden, Diane ; Minhajuddin, Abu T. ; Fishman, Marc J. ; Stitzer, Maxine L. ; Adinoff, Bryon H. ; Trivedi, Madhukar H. ; Weiss, Roger D. ; Potter, Jennifer Sharpe ; Poole, Sabrina A. ; Woody, George E.
 Journal of the American Academy of Child & Adolescent Psychiatry 2011;50(11):1120-1128. [doi: 10.1016/j.jaac.2011.07.010].
 
18. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. doc type doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Byrne, Mimmie ; Connery, Hilary Smith ; Dickinson, William ; Gardin, John G. II ; Griffin, Margaret L. ; Gourevitch, Marc N. ; Haller, Deborah L. ; Hasson, Albert L. ; Huang, Zhen ; Jacobs, Petra ; Kosinski, Andrzej S. ; Lindblad, Robert ; McCance-Katz, Elinore F. ; Provost, Scott E. ; Selzer, Jeffrey A. ; Somoza, Eugene C. ; Sonne, Susan C. ; Ling, Walter
 Archives of General Psychiatry 2011;68(12):1238-1246. [doi: 10.1001/archgenpsychiatry.2011.121].
 
19. Clinical Correlates of Health-Related Quality of Life Among Opioid-Dependent Patients. doc type
  Heslin, Kevin C. ; Stein, Judith A. ; Heinzerling, Keith G. ; Pan, Deyu ; Magladry, Christine ; Hays, Ron D.
 Quality of Life Research 2011;20(8):1205-1213. [doi: 10.1007/s11136-011-9858-y].
 
20. A Community-Based, Two-Phase Randomized Controlled Trial of Buprenorphine With and Without Individual Drug Counseling for the Treatment of Opioid Analgesic Addiction. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D. ; Jacobs, Petra ; Ling, Walter
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010..
 
21. Data from the CTN Platform Study: Major Findings. doc type
  Roman, Paul M. ; Abraham, Amanda J.
 Presentation from the CTN Steering Committee Meeting, March 2009; CTN 10th Anniversary Symposium, 2010, and the CTN Steering Committee Meeting, September 2010.
 
22. Cost-Effectiveness of Extended Buprenorphine-Naloxone Treatment for Opioid-Dependent Youth: Data from a Randomized Trial. doc type
  Polsky, Daniel ; Glick, Henry A. ; Yang, Jianing ; Subramaniam, Geetha A. ; Poole, Sabrina A. ; Woody, George E.
 Addiction 2010;105(9):1616-1624. [doi: 10.1111/j.1360-0443.2010.03001.x].
 
23. Effects of Participant Compensation Amounts on Missing Data and Urine Screen Results Among Adolescent and Young Adult Opioid Dependent Clinical Trial Participants. doc type
  Wilcox, Claire E. ; Bogenschutz, Michael P. ; Nakazawa, Masato ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
24. Concordance Between Self-Report and Urine Drug Screen Data in Adolescent Opioid Dependent Clinical Trial Participants. doc type
  Nakazawa, Masato ; Wilcox, Claire E. ; Bogenschutz, Michael P. ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
25. Extended vs. Short-Term Buprenorphine/Naloxone for Treatment of Opioid-Addicted Youth. doc type
  Woody, George E. ; Poole, Sabrina A. ; Subramaniam, Geetha A. ; Dugosh, Karen L. ; Bogenschutz, Michael P. ; Abbott, Patrick J.
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
26. Cost-Effectiveness of Extended Buprenorphine/Naloxone Treatment for Opioid Dependent Youth: Data from a Randomized Trial. doc type
  Polsky, Daniel ; Glick, Henry A. ; Yang, Jianing ; Subramaniam, Geetha A. ; Poole, Sabrina A. ; Woody, George E.
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
27. Adoption of Medication Treatment for Adolescent and Young Adult Opioid Dependence. doc type
  Fishman, Marc J. ; Khan, Lawangeen ; Garrett, Shannon ; O'Neill, Lawrence ; Hiken, Lauren ; Shah, Syed ; Bokhari, Asad
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
28. Predictors of Buprenorphine-Naloxone Dosing in a 12-Week Treatment Trial for Opioid-Dependent Youth: Secondary Analyses from a NIDA Clinical Trials Network Study. doc type
  Weiss, Roger D. ; Chakrabarti, Amit ; Woody, George E. ; Griffin, Margaret L. ; Subramaniam, Geetha A. ; Dodd, Dorian R.
 Presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
29. Buprenorphine Treatment for Young Adults (Blending Team Product). doc type
  McNicholas, Laura F. ; Bogenschutz, Michael P. ; Subramaniam, Geetha A. ; Garrett, Shannon ; Storti, Susan A. ; Woody, George E. ; Freese, Thomas E. ; Waters, Pamela ; Durham, Thomas
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2010.
 
30. HIV Risk Behavior in Treatment-Seeking Opioid-Dependent Youth: Results from a NIDA Clinical Trials Network Multisite Study. doc type
  Meade, Christina S. ; Weiss, Roger D. ; Fitzmaurice, Garrett M. ; Poole, Sabrina A. ; Subramaniam, Geetha A. ; Patkar, Ashwin A. ; Connery, Hilary Smith ; Woody, George E.
 Journal of Acquired Immune Deficiency Syndromes 2010;55(1):65-72. [doi: 10.1097/QAI.0b013e3181d916db].
 
31. Buprenorphine Treatment of Prescription Opiate Addiction. doc type
  McCarthy, John
 Presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
32. Young Opioid Abusers Benefit from Extended Buprenorphine-Naloxone Treatment. doc type
  Whitten, Lori
 NIDA Notes 2010;23(1):8-9.
 
33. Study Results from the Clinical Trials Network's First 10 Years: Where Do They Lead? doc type
  Wells, Elizabeth A. ; Saxon, Andrew J. ; Calsyn, Donald A. ; Jackson, T. Ronald ; Donovan, Dennis M.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S14-S30. [doi: 10.1016/j.jsat.2009.12.009].
 
34. From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. doc type
  Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].
 
35. Pain and Continued Opioid Use in Individuals Receiving Buprenorphine-Naloxone for Opioid Detoxification: Secondary Analyes from the Clinical Trials Network. doc type
  Potter, Jennifer Sharpe ; Chakrabarti, Amit ; Domier, Catherine P. ; Hillhouse, Maureen P. ; Weiss, Roger D. ; Ling, Walter
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S80-S86. [doi: 10.1016/j.jsat.2009.12.007].
 
36. Provision of Ancillary Medications During Buprenorphine Detoxification Does Not Improve Treatment Outcomes. doc type
  Hillhouse, Maureen P. ; Domier, Catherine P. ; Chim, David ; Ling, Walter
 Journal of Addictive Diseases 2010;29(1):23-29. [doi: 10.1080/10550880903438925].
 
37. A Method to Diagnose Opioid Dependence Resulting from Heroin Versus Prescription Opioids Using the Composite International Diagnostic Interview. doc type
  Potter, Jennifer Sharpe ; Prather, Kristi ; Kropp, Frankie B. ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Mohamedi, Nadia ; Copersino, Marc L. ; Weiss, Roger D.
 Contemporary Clinical Trials 2010;31(2):185-188. [doi: 10.1016/j.cct.2010.01.002].
 
38. Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Copersino, Marc L. ; Prather, Kristi ; Jacobs, Petra ; Provost, Scott E. ; Chim, David ; Selzer, Jeffrey A. ; Ling, Walter
 American Journal on Addictions 2010;19(2):141-146. [doi: 10.1111/j.1521-0391.2009.00017.x].
 
39. Effects of Buprenorphine and Hepatitis C on Liver Enzymes in Adolescents and Young Adults. doc type
  Bogenschutz, Michael P. ; Abbott, Patrick J. ; Kushner, Robert ; Tonigan, J. Scott ; Woody, George E.
 Journal of Addiction Medicine 2010;4(4):211-216. [doi: 10.1097/ADM.0b013e3181c4e27e].
 
40. A Multi-Site, Two-Phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, Design, and Methodology. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Huang, Zhen ; Jacobs, Petra ; Hasson, Albert L. ; Lindblad, Robert ; Connery, Hilary Smith ; Prather, Kristi ; Ling, Walter
 Contemporary Clinical Trials 2010;31(2):189-199. [doi: 10.1016/j.cct.2010.01.003].
 
41. Buprenorphine Adoption in the National Drug Abuse Treatment Clinical Trials Network. doc type
  Knudsen, Hannah K. ; Abraham, Amanda J. ; Johnson, J. Aaron ; Roman, Paul M.
 Journal of Substance Abuse Treatment 2009;37(3):307-312. [doi: 10.1016/j.jsat.2008.12.004].
 
42. Use of an Adaptive Treatment Research Design in a CTN Study of Prescription Opioid Dependence Treatment. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
43. Predictors of Outcome for Short-Term Medically Supervised Opioid Withdrawal During a Randomized, Multicenter Trial of Buprenorphine-Naloxone and Clonidine in the NIDA Clinical Trials Network. doc type
  Ziedonis, Douglas M. ; Amass, Leslie ; Steinberg, Marc ; Woody, George E. ; Krejci, Jonathan ; Annon, Jeffrey J. ; Cohen, Allan J. ; Waite-O'Brien, Nancy ; Stein, Susan M. ; McCarty, Dennis ; Reid, Malcolm S. ; Brown, Lawrence S. Jr. ; Maslansky, Robert ; Winhusen, Theresa M. ; Babcock, Dean ; Brigham, Gregory S. ; Muir, Joan A. ; Orr, Deborah ; Buchan, Betty J. ; Horton, Terry ; Ling, Walter
 Drug and Alcohol Dependence 2009;99(1-3):28-36. [doi: 10.1016/j.drugalcdep.2008.06.016].
 
44. Extended vs. Short-Term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial. doc type doc type
  Woody, George E. ; Poole, Sabrina A. ; Subramaniam, Geetha A. ; Dugosh, Karen L. ; Bogenschutz, Michael P. ; Abbott, Patrick J. ; Patkar, Ashwin A. ; Publicker, Mark ; McCain, Karen ; Potter, Jennifer Sharpe ; Forman, Robert F. ; Vetter, Victoria ; McNicholas, Laura F. ; Blaine, Jack D. ; Lynch, Kevin G. ; Fudala, Paul
 JAMA 2008;300(17):2003-2011. [doi: 10.1001/jama.2008.574].
 
45. Changes in 12-Step Cognitions Among Treatment-Seeking Adolescents. doc type
  Tonigan, J. Scott ; Forcehimes, Alyssa A. ; Bogenschutz, Michael P.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2008.
 
46. Effects of Buprenorphine and Hepatitis C on Liver Enzymes in Adolescents and Young Adults. doc type
  Bogenschutz, Michael P. ; Kushner, Robert ; Tonigan, J. Scott ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2008.
 
47. Understanding and Utilizing Buprenorphine in the Treatment and Short Term Detox of Opioid Addiction. doc type
  Freese, Thomas E. ; Detmer, Mary Ann ; Brigham, Gregory S.
 Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.
 
48. Statistical Methodology for a SMART Design in the Development of Adaptive Treatment Strategies. doc type
  Scott, Alena I. ; Levy, Janet A. ; Murphy, Susan A.
 State College, PA : The Methodology Center, Pennsylvania State University, Technical Report #07-82, 2007, 30p..
 
49. Integrating Services Research into CTN Clinical Trials: The Synergy is in the Details. doc type
  Perl, Harold I.
 Presented at the Addiction Health Services Research Conference, October 15-17, 2007, Athens, GA.
 
50. A Federal Effort to Bridge the Gap: NIDA's Blending Initiative Places Community Providers at the Leading Edge of New Treatment Knowledge. doc type
  Condon, Timothy P.
 Addiction Professional 2007;5(5):26-31.
 
51. The Science of Treatment: Dissemination of Research-Based Drug Addiction Treatment Findings (Blending Team Product). doc type
  National Institute on Drug Abuse (NIDA) ; Substance Abuse and Mental Health Services Administration (SAMHSA) ; Addiction Technology Transfer Center (ATTC) National Office
 Produced by the NIDA/SAMHSA-ATTC Blending Initiative, 2007.
 
52. Research Network Involvement and Addiction Treatment Center Staff: Counselor Attitudes toward Buprenorphine. doc type
  Knudsen, Hannah K. ; Ducharme, Lori J. ; Roman, Paul M.
 American Journal on Addictions 2007;16(5):365-371 [doi: 10.1080/10550490701525418].
 
53. Short Term Opioid Withdrawal Using Buprenorphine (Blending Team Product). doc type
  Freese, Thomas E. ; Brigham, Gregory S. ; Finnerty, Beth ; Gresham-Morrison, Kay ; Harrer, Judith M. ; McCarty, Dennis ; Storti, Susan A.
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2006.
 
54. Challenges in the Adoption of New Pharmacotherapeutics for Addiction to Alcohol and Other Drugs. doc type
  Saxon, Andrew J. ; McCarty, Dennis
 Pharmacology & Therapeutics 2005;108:119-128. [doi: 10.1016/j.pharmthera.2005.06.014].
 
55. Prescription Opioid Addiction Treatment Study: Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
56. A Multi-Center Randomized Trial of Buprenorphine-Naloxone Versus Clonidine for Opioid Detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. doc type doc type
  Ling, Walter ; Amass, Leslie ; Shoptaw, Steven ; Annon, Jeffrey J. ; Hillhouse, Maureen P. ; Babcock, Dean ; Brigham, Gregory S. ; Harrer, Judith M. ; Reid, Malcolm S. ; Muir, Joan A. ; Buchan, Betty J. ; Orr, Deborah ; Woody, George E. ; Krejci, Jonathan ; Ziedonis, Douglas M. ; CTN Buprenorphine Study Team (CTN-0001/0002)
 Addiction 2005; 100(8):1090-1100. [doi: 10.1111/j.1360-0443.2005.01154.x] Correction: Addiction 2006;101(9):1374.
 
57. Buprenorphine Treatment: A Training for Multidisciplinary Addiction Professionals (Blending Team Product) doc type doc type
  Amass, Leslie ; Brigham, Gregory S. ; Clare, Glenda ; Dixon, Gail ; Finnerty, Beth ; Freese, Thomas E. ; Strain, Eric ; Martin, Judith ; McCann, Michael J. ; Obert, Jeanne L. ; Wesson, Donald ; Addiction Technology Transfer Center (ATTC) National Office ; OASIS Clinic
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2005.
 

New Search